# Intravenous CAngrelor in High-bleeding Risk Patients Undergoing percutaneouS Coronary Intervention (ICARUS) Registry

> **NCT05505591** · — · UNKNOWN · sponsor: **Universita degli Studi di Genova** · enrollment: 900 (estimated)

## Conditions studied

- Bleeding
- Coronary Artery Disease
- Myocardial Infarction

## Interventions

- **DRUG:** Cangrelor

## Key facts

- **NCT ID:** NCT05505591
- **Lead sponsor:** Universita degli Studi di Genova
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-06
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2022-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05505591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05505591, "Intravenous CAngrelor in High-bleeding Risk Patients Undergoing percutaneouS Coronary Intervention (ICARUS) Registry". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05505591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*